GlassScriptPhysician profile
James S Albin
NPI 1366433401
$1,792.91
in general payments reported to CMS, 2019-2025
25 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $102 · 2021: $501 · 2022: $258 · 2023: $281 · 2024: $298 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.27 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $465.68 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $312.79 | 2019-2024 | Liletta |
| Daiichi Sankyo INC. | $169.10 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $118.83 | 2022-2025 | |
| Organogenesis INC. | $110.79 | 2021 | |
| Pfizer INC. | $99.70 | 2019-2025 | |
| Organon LLC | $57.09 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $57.02 | 2021 | |
| Hologic Sales and Service, LLC | $55.71 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Amgen INC. | $52.25 | 2019-2025 | Evenity, Prolia |
| Ethicon US, LLC | $35.25 | 2023 | Echelon Circular |
| Channel Medsystems, INC. | $32.05 | 2022 | |
| Therapeuticsmd, INC. | $25.34 | 2020 | |
| Allergan, INC. | $25.08 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.41 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18.76 | 2024 | Ligasure |
| Pacira Pharmaceuticals Incorporated | $18.29 | 2025 | Exparel |
| Novartis Pharmaceuticals Corporation | $17.48 | 2025 | |
| Currax Pharmaceuticals LLC | $15.50 | 2022 | |
| Agile Therapeutics, INC. | $15.16 | 2021 | |
| Ironwood Pharmaceuticals, INC | $14.88 | 2019 | |
| Shield Therapeutics INC | $14.46 | 2023 | Accrufer |
| Biogen, INC. | $14.18 | 2025 | Zurzuvae |
| Heron Therapeutics, INC. | $13.81 | 2025 | Zynrelef |
| Hologic INC | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Albin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.